Close Menu

A Duke University-led team characterizes an autism spectrum disorder-associated, alternatively spliced version of the ANK2 gene, which produces a so-called giant ankyrin-B (ankB). Using CRISPR-Cas9 gene editing, the researchers produced mice with ASD-related splice changes affecting exon 37 of ANK2 before tracking mouse behavior and brain connectivity — analyses that highlighted enhanced neuronal axon branching and other brain connection changes in the giant ankB mice.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

Time magazine looks into how liquid biopsies are changing cancer care.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.